Drug Trial Radar · NCT06679101
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Last checked: Nov 20, 2026Latest source record: Apr 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
520
Planned (sponsor's estimate)
Start
Dec 16, 2024
Primary completion
Apr 28, 2031
Study completion Apr 28, 2031
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Nov 7, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negative status compared with DRd in participants with TI-NDMM.
Conditions
- Multiple Myeloma
- Newly Diagnosed Multiple Myeloma
Interventions
Belantamab mafodotinDrug
Belantamab mafodotin will be administered.
LenalidomideDrug
Lenalidomide will be administered.
DexamethasoneDrug
Dexamethasone will be administered.
DaratumumabDrug
Daratumumab will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- PFSTime frame: Up to approximately 7 years
- Number of Participants Achieving MRD Negative StatusTime frame: Up to approximately 7 years
Locations
181 sites in 24 countries. Site status is shown where the registry gives one.
GSK Investigational Site
Mobile, Alabama · Recruiting
GSK Investigational Site
Phoenix, Arizona · Recruiting
GSK Investigational Site
Beverly Hills, California · Recruiting
GSK Investigational Site
Pasadena, California · Recruiting
GSK Investigational Site
Aurora, Colorado · Recruiting
GSK Investigational Site
Washington D.C., District of Columbia · Recruiting
GSK Investigational Site
Englewood, Florida · Recruiting
GSK Investigational Site
Lady Lake, Florida · Recruiting
GSK Investigational Site
Pembroke Pines, Florida · Recruiting
GSK Investigational Site
Saint Augustine, Florida · Recruiting
GSK Investigational Site
Atlanta, Georgia · Recruiting
GSK Investigational Site
Portland, Maine · Recruiting
GSK Investigational Site
Worcester, Massachusetts · Recruiting
GSK Investigational Site
Ann Arbor, Michigan · Recruiting
GSK Investigational Site
Detroit, Michigan · Recruiting
GSK Investigational Site
Billings, Montana · Recruiting
GSK Investigational Site
Hackensack, New Jersey · Recruiting
GSK Investigational Site
New York, New York · Recruiting
GSK Investigational Site
Stony Brook, New York · Recruiting
GSK Investigational Site
Charlotte, North Carolina · Recruiting
GSK Investigational Site
Winston-Salem, North Carolina · Recruiting
GSK Investigational Site
Columbus, Ohio · Recruiting
GSK Investigational Site
Providence, Rhode Island · Recruiting
GSK Investigational Site
Austin, Texas · Recruiting
GSK Investigational Site
Austin, Texas · Recruiting
GSK Investigational Site
Kingwood, Texas · Recruiting
GSK Investigational Site
San Antonio, Texas · Recruiting
GSK Investigational Site
Tyler, Texas · Recruiting
GSK Investigational Site
Fairfax, Virginia · Recruiting
GSK Investigational Site
Puyallup, Washington · Recruiting
GSK Investigational Site
Capital Federal, Argentina · Recruiting
GSK Investigational Site
Ciudad Autonoma de Buenos Aire, Argentina · Recruiting
GSK Investigational Site
Córdoba, Argentina · Recruiting
GSK Investigational Site
Rosario, Argentina · Recruiting
GSK Investigational Site
Viedma, Argentina · Recruiting
GSK Investigational Site
Fitzroy, Australia · Recruiting
GSK Investigational Site
Herston, Australia · Recruiting
GSK Investigational Site
St Leonards, Australia · Recruiting
GSK Investigational Site
Gosford NSW, New South Wales, Australia · Recruiting
GSK Investigational Site
Box Hill, Victoria, Australia · Recruiting
Showing 40 of 181 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.